United States Hormonal Contraceptive Market was valued at USD 8 Billion in 2022 and is projected to reach USD 12 Billion by 2030, growing at a CAGR of 6.1% from 2024 to 2030.
The U.S. hormonal contraceptive market has experienced significant growth in recent years, driven by evolving consumer preferences and socio-political factors. As of 2023, the market was valued at approximately $18.1 billion and is projected to reach $26.7 billion by 2032, reflecting a compound annual growth rate (CAGR) of 4.4% between 2024 and 2032. This growth is influenced by several key factors:
Increased Demand for Contraceptives: Post the 2024 presidential election, there was a notable surge in requests for long-term birth control methods and permanent sterilizations. Healthcare providers reported a significant rise in demand for intrauterine device (IUD) replacements and tubal ligations, driven by concerns over potential changes in reproductive rights under the new administration.
Stockpiling of Emergency Contraceptives: In anticipation of possible restrictions on reproductive rights, many individuals have proactively sought to secure emergency contraception. Online retailers have observed substantial increases in sales of emergency contraceptives, with some reporting up to a 1,650% surge in new patient transactions around the election period.
Over-the-Counter Availability: A significant development in 2024 was the approval of Opill, a progestin-only birth control pill, for over-the-counter sales. This milestone, achieved after over two decades of advocacy, has made hormonal contraception more accessible, especially for those with limited healthcare access.
Market Growth and Projections: The U.S. contraceptive market was estimated at $8.76 billion in 2023 and is projected to grow at a CAGR of 5.20% from 2024 to 2030. This growth is attributed to increased awareness about sexual health and family planning among adolescents and young adults, as well as government programs enhancing access to contraceptives.
Emerging Non-Hormonal Alternatives: While hormonal contraceptives remain popular, there is a growing interest in non-hormonal options. Innovations such as non-hormonal gels are gaining traction, appealing to individuals who prefer non-hormonal methods.
These developments underscore the dynamic nature of the U.S. hormonal contraceptive market, influenced by political, social, and technological factors. Consumers are increasingly proactive about their reproductive health, seeking both traditional and alternative contraceptive methods amidst a changing regulatory landscape.
Get an In-Depth Research Analysis of the US Hormonal Contraceptive Market Size And Forecast [2025-2032]
Ansell Limited
Bayer AG
Church and Dwight Co
Johnson and Johnson
Mayer Laboratories
Merck and Co
Mylan N.V.
Pfizer
Teva Pharmaceutical Industries
The Female Health Company
Organon International
Afaxys
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the US Hormonal Contraceptive Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the US Hormonal Contraceptive Market
Oral Contraceptives
Injectables
Implants
Intrauterine Devices (IUDs)
Topical Contraceptives
Vaginal Rings
Combination Pills
Progestin-Only Pills
Emergency Contraceptives
Hormonal IUDs
Implants
Women (Reproductive Age)
Adolescents
Postpartum Women
Women with Medical Conditions
Retail Pharmacies
Online Pharmacies
Hospital Pharmacies
Drug Stores
Pills
Injectables
Implants
Topical Gels/Creams
Intrauterine Devices (IUDs)
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Hormonal Contraceptive Market Research Analysis
1. Introduction of the US Hormonal Contraceptive Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. US Hormonal Contraceptive Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. US Hormonal Contraceptive Market, By Type
6. US Hormonal Contraceptive Market, By Application
7. US Hormonal Contraceptive Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. US Hormonal Contraceptive Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading US Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/